Veraxa Biotech Holding AG (VRXAW) Notes Payables (2025)
Veraxa Biotech Holding AG (VRXAW) posted quarterly Notes Payables of $1.3 million for Q4 2025.
Veraxa Biotech Holding AG (VRXAW) Notes Payables (2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXAW) has reported Notes Payables for 1 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Notes Payables changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, changed N/A from the prior year.
- Notes Payables was little changed at $1.3 million in Q4 2025 per VRXAW's latest filing.
- Across five years, Notes Payables topped out at $1.3 million in Q4 2025 and bottomed at $1.3 million in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.25 Mn |